Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination. Geers D, Aguilar-Bretones M, Zaeck LM, Gill PA, et al. J Infect 2026;92:106681.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Geers D, Aguilar-Bretones M, Zaeck LM, Gill PA, et al. Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination. J Infect 2026;92:106681.
PMID: 41519394